September 9, 2023 — Two years ago, we got the first signal. It looked like deaths due to heart disease were no longer dropping. In fact, they went up in 2020. This week, the reason why became pretty clear. A new study in the Journal of the American Heart Association documented a tripling of obesity-related heart deaths over the […]
August 21, 2023 — How much might the application of new insights from the SELECT study of treating obesity do for preventing heart attacks, strokes, and deaths. A first pass at answering this question appeared in Cardiovascular Drugs and Therapy last week. Nathan Wong, Hridhay Karthikeyan, and Wenjun Fan estimated the potential for semaglutide treatment to lower cardiovascular disease […]
August 8, 2023 — No two ways about it. This is huge. The topline results of the SELECT trial of cardiovascular outcomes with semaglutide in obesity are out and unequivocal. Semaglutide cuts deaths and cardiovascular (CV) events in people with overweight and obesity. An important detail in the announcement of these results regards the three components of the primary […]
July 8, 2023 — It’s coming. Sometime before September we will be hearing about the results of the SELECT outcomes study of semaglutide in people with obesity and we may as well start getting ready to argue about it now. Because value is in the eye of the beholder. And this study is all about the long-term health value […]
May 20, 2023 — ECO2023 closed today with a clear focus on future progress in obesity. Lee Kaplan offered a view of what that future might look like with a focus on access and delivery of chronic care for obesity. Kaplan told us the future of obesity care lies in getting beyond merely saying that obesity is a disease. […]
December 16, 2022 — We’re zooming toward the end of 2022, so it’s hard to resist looking back to see which of the posts on ConscienHealth you read the most. We are grateful for the smart and diverse people who take the time to read what we post here. Seeing what captures your attention teaches us a thing or […]
September 16, 2022 — Twenty years ago in the New England Journal of Medicine, the Diabetes Prevention Program showed that intensive lifestyle coaching for weight control can cut the risk of diabetes for people with prediabetes by 58 percent over a period of three years. At the upcoming EASD meeting, Tim Garvey and colleagues will present an analysis 10-year […]
August 4, 2022 — Sometimes the hardest news to digest is no news. This was certainly the case yesterday for Novo Nordisk, the market leader in anti-obesity medicines. Their stock dropped by nearly 13 percent when the company told investors that there would be no news on the semaglutide SELECT study. So why was no news seemingly such big […]
August 4, 2021 — Bariatric surgery provides a benefit for reducing risks to heart health. This has been pretty clear for years now. Still, utilization remains low because the procedure seems daunting to many who need it. But a recent study suggests that an anti-obesity medicine – orlistat – might also reduce risks to heart health. In the European […]
November 9, 2019 — We’ve had our full dose of Las Vegas. But ObesityWeek has given us more to think about than shows and casinos. With record attendance of 5,800, it was more than any one person could absorb. No doubt, everyone has returned home with a different experience from ObesityWeek. So here are our ten top take-home messages. […]
